Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 207

1.

[Update on the progestin-only contraception].

Madelenat P, Koskas M; Groupe de réflexion sur la contraception progestative.

J Gynecol Obstet Biol Reprod (Paris). 2008 Nov;37(7):637-60. doi: 10.1016/j.jgyn.2008.06.013. Epub 2008 Sep 27. French.

2.

Progestin-only oral contraception: a comprehensive review.

McCann MF, Potter LS.

Contraception. 1994 Dec;50(6 Suppl 1):S1-195. Review.

PMID:
10226677
3.

[The statement of Polish Gynecological Society experts on oral use of contraceptive 75 microg desogestrel minipill in different clinical cases--state of art in 2008].

Debski R, Kotarski J, Paszkowski T, Pawelczyk L, Skrzypulec V, Tomaszewski J; Polish Gynecological Society.

Ginekol Pol. 2009 Jan;80(1):63-75. Polish.

PMID:
19323063
4.

[Contraception at 40].

André G.

Gynecol Obstet Fertil. 2002 Jul-Aug;30(7-8):616-24. Review. French.

PMID:
12199046
5.

Hormonal contraception in women at risk of vascular and metabolic disorders: guidelines of the French Society of Endocrinology.

Gourdy P, Bachelot A, Catteau-Jonard S, Chabbert-Buffet N, Christin-Maître S, Conard J, Fredenrich A, Gompel A, Lamiche-Lorenzini F, Moreau C, Plu-Bureau G, Vambergue A, Vergès B, Kerlan V.

Ann Endocrinol (Paris). 2012 Nov;73(5):469-87. doi: 10.1016/j.ando.2012.09.001. Epub 2012 Oct 15.

PMID:
23078975
6.
7.

[Current status of estrogen-progestational contraception].

Tabaste JL, Lesourd-Pontonnier F.

Rev Fr Gynecol Obstet. 1994 Jul-Sep;89(7-9):406-8. Review. French.

PMID:
7973341
8.

Clinical profile of contraceptive progestins.

Benagiano G, Primiero FM, Farris M.

Eur J Contracept Reprod Health Care. 2004 Sep;9(3):182-93. Review.

PMID:
15697108
9.

At III content and antithrombin in activity in oestrogen-progestogen and progestogen-only treated women.

Conard J, Cazenave B, Samama M, Horellou MH, Zorn JR, Neau C.

Thromb Res. 1980 Jun 1;18(5):675-81.

PMID:
7414554
10.

[Summary of the practice guideline 'Hormonal contraception' (second revision) from the Dutch College of General Practitioners].

Boukes FS, Beijderwellen L, van der Does FE, Assendelft WJ.

Ned Tijdschr Geneeskd. 2004 Jun 26;148(26):1285-9. Dutch.

PMID:
15279211
11.
12.

Progestogen therapies: differences in clinical effects?

Wiegratz I, Kuhl H.

Trends Endocrinol Metab. 2004 Aug;15(6):277-85. Review.

PMID:
15358281
13.

[Oral contraceptives and breast cancer].

Zoricić D, Ambrozić B, Perić D.

Lijec Vjesn. 1998 Dec;120(12):392-7. Review. Croatian.

PMID:
19658362
14.

[Effect of hormonal contraception on bone mineral density].

Trémollières F.

Gynecol Obstet Fertil. 2005 Jul-Aug;33(7-8):520-5. Review. French.

PMID:
16005661
15.

Intrauterine devices: an effective alternative to oral hormonal contraception.

[No authors listed]

Prescrire Int. 2009 Jun;18(101):125-30.

PMID:
19637436
16.

Effects on breast tissue of exogenous oestrogens and progestogens.

Anderson TJ.

Acta Obstet Gynecol Scand Suppl. 1986;134:9-13. Review. No abstract available.

PMID:
2949482
17.

[Rationalizing progestin-only contraception (except IUS with levonorgestrel)].

Jamin C, Madelenat P.

Gynecol Obstet Fertil. 2008 May;36(5):557-62. doi: 10.1016/j.gyobfe.2008.01.015. Epub 2008 May 15. Review. French.

PMID:
18485786
18.

Use of hormonal contraception in adolescents: skeletal health issues.

Tolaymat LL, Kaunitz AM.

Curr Opin Obstet Gynecol. 2009 Oct;21(5):396-401. doi: 10.1097/GCO.0b013e32832c9cc6. Review.

PMID:
19491681
20.

Limited knowledge on progestogen-only contraception and risk of venous thromboembolism.

Bergendal A, Odlind V, Persson I, Kieler H.

Acta Obstet Gynecol Scand. 2009;88(3):261-6. doi: 10.1080/00016340902730375. Review.

PMID:
19172422

Supplemental Content

Support Center